Integrative structural biology of pathological tau protein, an appealing therapeutic target for Alzheimer's disease modifying drugs
We are aiming to:
Project coordinator: CEITEC MU (Czech Republic)
Project partners: Institute of Neuroimmunology, Slovak Academy of Sciences (Slovak Republic) • Latvian Institute of Organic Synthesis (Latvia) • Royal College of Surgeons (Ireland) • University of Pittsburgh (USA) • Oregon State University (USA) • University Health Network (Canada) • National University of Cuyo (Argentina)
Project duration: 66 months (01.01.2020 - 30.06.2025)
Project call: H2020-MSCA-RISE-2019
Total budget: 1 058 000 EUR
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska- Curie grant agreement no. 873127 – InterTAU.
This website reflects only the author's view and the Research Executive Agency (REA) is not responsible for any use that may be made of the information it contains.